Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis

Cytotherapy

Volumn 11, Issue 3, 2009, Pages 299-306

  Zhang, Cheng ^a   Zhou, Chang ^a,b   Teng, Ji Jun ^a   Zhao, Ren Liang ^a   Song, Yu Qiang ^b  

^a QINGDAO UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Amyotrophic lateral sclerosis; Bone marrow stromal cells; Intrathecal transplantation; SOD1

Indexed keywords

SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW STROMA CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CELL COUNT; CELL LOSS; CELL MIGRATION; CELL PROTECTION; CELLULAR DISTRIBUTION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUMBAR SPINAL CORD; MALE; MOTONEURON; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TRANSGENIC MOUSE; WEIGHT REDUCTION;

EID: 68049116659     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240902806986     Document Type: Article

References (22)

1. Guerney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD et al. Motor Neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science, 1994;264(5166):1772-5
2. Silani V, Cova L, Corbo M, Ciammola A, Polli E. Stem-cell therapy for amyotrophic lateral sclerosis. Lancet 2004;364 (9429):200-2.
3. English D, Klasko SK, Sanberg PR. Elusive mechanisms of 'stem cell'-mediated repair of cerebral damage. Exp Neurol 2006; 199(1):10-5.
4. Garbuzova-Davis S, Willing AE, Zigova T, Saporta S, Justen EB, Lane JC et al. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: Distribution, migration, and differentiation. J Hematother Stem Cell Res 2003;12(3):255-70.
5. Borlongan CV, Hadman M, Sanberg CD, Sanberg PR. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004;35(10):2385-9.
6. Habisch HJ, Janowski M, Binder D, Kuzma-Kozakiewicz M, Widmann A, Habich A, et al. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: Limited intraparenchyma migration and survival narrows therapeutic effects. J Neural Transm. 2007;114(11):1395-406.
7. Corti S, Locatelli F, Papadimitriou D, Donadoni C, Del Bo R, Crimi M et al. Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1. Hum Mol Genet 2006;15(2):167-87.
8. Heiman-Patterson TD, Deitch JS, Blankenhorn EP, Erwin KL, Perreault MJ, Alexander BK et al. Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J Neurol Sci 2005;236(1-2):1-7.
9. Weydt P, Hong SY, Kliot M, Moller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 2003;14(7):1051-4.
10. Zhou C, Zhao CP, Zhang C, Wu GY, Xiong F, Zhang C. A method comparison in monitoring disease progression of G93A mouse model of ALS. Amyotroph Lateral Scler 2007;8(6):366-72.
11. McHanwell S, Biscoe TJ. The sizes of motoneurons supplying hindlimb muscles in the mouse. Proc R Soc Lond B Biol Sci 1981;213(1191):201-16.
12. Wu S, Suzuki Y, Kitada M, Kataoka K, Kitaura M, Chou H et al. New method for transplantation of neurosphere cells into injured spinal cord through cerebrospinal fluid in rat. Neurosci Lett 2002;318(2):81-4.
13. Bai H, Suzuki Y, Noda T et al. Dissemination and proliferation of neural stem cells on the spinal cord by injection into the fourth ventricle of the rat: A method for cell transplantation. J Neurosci Methods 2003;124(2):181-7.
14. Kerr DA, Lladó J, Shamblott MJ et al. Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. J Neurosci 2003;23(12):5131-40.
15. Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillée S, Rule M et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003; 302(5642):113-7.
16. Chopp M, Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol 2002;1(2):92-100.
17. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98(5):1076-84.
18. Potapova IA, Gaudette GR, Brink PR, Robinson RB, Rosen MR, Cohen IS et al. Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells 2007;25(7):1761-8.
19. Kaspar BK, Lladó J, Sherkat N, Rothstein JD, Gage FH. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 2003;301(5634):839-42.
20. Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004;429(6990):413-7.
21. Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 2005;8(1):85-92.
22. Corti S, Locatelli F, Donadoni C, Guglieri M, Papadimitriou D, Strazzer S et al. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 2004;127(11):2518-32.